Skip to content
Government Federal, Medical Health Aged Care

National Medicines Symposium 2025: Quality use of medicines in diabetes care

ACSQHC 3 mins read

17 October 2025

Diabetes is one of Australia’s most pressing and complex health challenges, affecting more than 1.5 million people and contributing to long-term complications, hospitalisations and premature deaths.

The National Medicines Symposium 2025, hosted by the Australian Commission on Safety and Quality in Health Care, will explore this issue under the theme ‘Quality use of medicines in people with diabetes’.

This free virtual event, on Wednesday 22 October 2025, will bring together national and international experts, clinicians, researchers, Aboriginal and Torres Strait Islander health practitioners, and people with lived experience, to explore how quality use of medicines, non-pharmacological care and emerging technologies can transform diabetes care.

More than 20 expert speakers will explore:

  • medicines management in type 1 and type 2 diabetes
  • person-centred prescribing and deprescribing
  • the importance of care at different life stages, including pregnancy, adolescence and ageing
  • equity and access to culturally safe care
  • integrated care models, including pharmacists embedded in primary care and the Diabetes Alliance Program Plus (DAP+)
  • the importance of self-management and non-pharmacological strategies such as nutrition, movement and mental health.

Chronic conditions, including diabetes, are an underlying or associated cause of 90% of all deaths in Australia. People with diabetes also face a higher risk of sepsis and complications, making safe and appropriate diabetes medicines use critical.

Associate Professor Liz Marles, Clinical Director for the Commission and a general practitioner, said medicines for diabetes must be tailored to the individual.

“Quality use of medicines in diabetes is not just about the correct prescription. It is about safe, effective, person-centred care that adapts to an individual’s life stage, cultural needs, and health priorities. This Symposium is an opportunity to drive national conversations and practical action to improve care for every person living with diabetes,” said Associate Professor Marles.

Professor Andrew McLachlan, Head of School and Dean of Pharmacy at the University of Sydney, and Symposium facilitator, highlighted the importance of collaboration and innovation.

"Emerging medicines, technology, and care models present new opportunities to improve outcomes for people with diabetes. The Symposium will showcase how clinicians, researchers and consumers can work together to advance safe and effective diabetes management."

Key speakers include:

  • Distinguished Professor David Simmons, Chief Medical Officer for Diabetes Australia, Professor of Medicine at Western Sydney University and District Advisor on Diabetes for the South Western Sydney Local Health District
  • Professor Jennifer Martin, Physician, Clinical Pharmacologist and President of the Royal Australasian College of Physicians
  • Professor Jonathan Shaw, Deputy Director of Clinical and Population Health, Baker Heart and Diabetes Institute
  • Professor Stephen Twigg, Head of Endocrinology, Royal Prince Alfred Hospital and Kellion Professor of Endocrinology, Stan Clark Chair in Diabetes and Head of Central Clinical School, The University of Sydney.
  • Professor Shamasunder Acharya, Director of Diabetes and Endocrinology and Program Lead for Diabetes Alliance Plus, Hunter New England Health District
  • Ms Sarah Lam, Senior Clinical Psychologist, Bankstown Hospital Diabetes Centre.

Register now

Don’t miss this opportunity to hear from Australia’s leading experts in diabetes care and medicines safety. Register today for the National Medicines Symposium 2025 and join the national conversation on how to improve quality use of medicines in people with diabetes.

 

Date: 22 October 2025

Time: 9:00 am – 3:30 pm AEDT

Format: Free, virtual event

Register now: safetyandquality.tv/NMS25

 

 

About the Commission

The Australian Commission on Safety and Quality in Health Care leads and coordinates national improvements in the safety and quality of health care based on the best available evidence. By working in partnership with patients, carers, clinicians, the Australian, state and territory health systems, the private sector, managers and healthcare organisations, the Commission aims to ensure that the health system is better informed, supported and organised to deliver safe and high-quality care. safetyandquality.gov.au

 

Media enquiries

Michelle Boland, Senior Communications Officer

E: [email protected]

Media

More from this category

  • Medical Health Aged Care
  • 07/12/2025
  • 01:41
Takeda Pharmaceutical Company Limited

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera

52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline NEWARK,…

  • Medical Health Aged Care
  • 06/12/2025
  • 02:11
Arthur D. Little

Arthur D. Little and Vega IT Unveil Joint Venture for Digital Innovation

NEW YORK–BUSINESS WIRE– Arthur D. Little (ADL) and Vega IT today announced the formation of Axceler8 Solutions, a 50/50 joint venture created to design,…

  • Contains:
  • Government Federal
  • 05/12/2025
  • 12:07
Doctors Reform Society

Specialist Fees Denying Patient Access to Care: Time to Act

Specialist Fees Denying Patient Access to Care: Time to Act “Reports that specialist fees are skyrocketing and reducing access of patients to specialist care are very concerning and long in the making” said Dr Tim Woodruff, President, Doctors Reform Society. “The Federal Government has been very slow to act on this issue despite repeated advice””, said Dr Woodruff. “We have long recommended dedicated federal funding to state governments to be used specifically to increase their specialist outpatient facilities, with the amount based on measured need in the community. We have also recently recommended that community specialist medical centres should be…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.